|
|
Fibrogen Inc (NASDAQ: FGEN) |
|
|
|
FGEN's EPS Net Growth by Quarter and Year
Fibrogen Inc 's EPS Net results by quarter and year
Select the Comparisons :
|
|
Select the Ratio:
|
|
FGEN EPS Net (in $) |
FY 2025 |
FY 2024 |
FY 2023 |
FY 2022 |
4th Quarter |
December |
-
|
0.18
|
-0.55
|
-0.70
|
3rd Quarter |
September |
-
|
-0.17
|
-0.65
|
-0.98
|
2nd Quarter |
June |
-
|
-0.16
|
-0.90
|
-0.78
|
1st Quarter |
March |
0.05
|
-0.33
|
-0.81
|
-0.68
|
FY |
|
0.05
|
-0.48
|
-2.91
|
-3.14
|
FGEN EPS Net first quarter 2025 Y/Y Growth Comment |
Fibrogen Inc in the first quarter 2025 achieved EPS Net of $ 0.05 compare to EPS net loss recorded in same quarter a year ago.
Looking into first quarter 2025 results within Major Pharmaceutical Preparations industry 29 other companies have achieved higher EPS Net growth. While Fibrogen Inc ' s EPS Net no change of 0% ranks overall at the positon no. 1623 in the first quarter 2025.
|
FGEN EPS Net ( Y/Y Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
December |
- |
- |
- |
- |
3rd Quarter |
September |
- |
- |
- |
- |
2nd Quarter |
June |
- |
- |
- |
- |
1st Quarter |
March |
- |
- |
- |
- |
FY |
|
- |
- |
- |
- |
FGEN EPS Net (Quarter on Quarter Growth %) |
2025
|
2024 |
2023 |
2022 |
4th Quarter |
December |
- |
- |
- |
- |
3rd Quarter |
September |
- |
- |
- |
- |
2nd Quarter |
June |
- |
- |
- |
- |
1st Quarter |
March |
-72.22 % |
- |
- |
- |
FY (Year on Year) |
|
- |
- |
- |
- |
EPS Net Y/Y Growth Statistics |
High |
Average |
Low |
-71.96 % |
-71.96 % |
-71.96 % |
(Mar 31 2025) |
|
|
|
EPS Net Y/Y Growth Statistics |
High |
Average |
Low |
-71.96 % |
-71.96 % |
-71.96 % |
(Mar 31 2025) |
|
|
|
EPS Net by Quarter for the Fiscal Years 2022, 2023, 2024, 2025 |
Fibrogen Inc 's Q/Q EPS Net Growth
EPS Net Q/Q Growth Statistics |
High |
Average |
Low |
-71.96 % |
-71.96 % |
-71.96 % |
(Mar 31 2025) |
|
|
FGEN's I. Quarter Q/Q EPS Net Comment |
In the I. Quarter 2025 Fibrogen Inc disclosed fall in EPS Net from the fourth quarter by -72.22% to $ 0.05 , from $ 0.18 achived in the previous reporting period.
Within Major Pharmaceutical Preparations industry 29 other companies have achieved higher EPS Net quarter on quarter growth. While Fibrogen Inc 's EPS Net growth quarter on quarter, overall rank is 1623. |
|
|
EPS Net Q/Q Growth Statistics |
High |
Average |
Low |
-71.96 % |
-71.96 % |
-71.96 % |
(Mar 31 2025) |
|
|
FGEN's I. Quarter Q/Q EPS Net Comment |
In the I. Quarter 2025 Fibrogen Inc disclosed fall in EPS Net from the fourth quarter by -72.22% to $ 0.05 , from $ 0.18 achived in the previous reporting period.
Within Major Pharmaceutical Preparations industry 29 other companies have achieved higher EPS Net quarter on quarter growth. While Fibrogen Inc 's EPS Net growth quarter on quarter, overall rank is 1623. |
|
Fibrogen Inc 's 12 Months EPS Net Growth Year on Year
EPS Net TTM Growth |
12 Months Ending (Mar 31 2025) |
12 Months Ending (Dec 31 2024) |
12 Months Ending (Sep 30 2024) |
12 Months Ending (Jun 30 2024) |
12 Months Ending (Mar 31 2024) |
Cumulative EPS Net 12 Months Ending |
$ -0.10 |
$ -0.48 |
$ -1.21 |
$ -1.69 |
$ -2.43 |
Y / Y EPS Net Growth (TTM) |
- |
- |
- |
- |
- |
Year on Year EPS Net Growth Overall
Ranking |
# |
# |
# |
# |
# |
Seqeuential EPS Net Change (TTM) |
- |
- |
- |
- |
- |
Seq. EPS Net Growth (TTM) Overall
Ranking |
# |
# |
# |
# |
# |
Cumulative EPS Net growth Comment |
Fibrogen Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. . |
|
|
EPS Net TTM Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
EPS Net TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# |
Sector |
# |
S&P 500 |
# |
|
Cumulative EPS Net growth
Comment |
Fibrogen Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. . |
EPS Net TTM Y/Y Growth Statistics |
High |
Average |
Low |
0 % |
0 % |
0 % |
|
|
|
EPS Net TTM Q/Q Growth Company Ranking |
Within: |
No. |
Industry |
# |
Sector |
# |
S&P 500 |
# |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com